awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26774024-0CFBE496-33A7-4DD4-80CD-F1AEDF6A959A
Q26774024-0CFBE496-33A7-4DD4-80CD-F1AEDF6A959A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26774024-0CFBE496-33A7-4DD4-80CD-F1AEDF6A959A
Bispecific antibodies and their applications
P2860
Q26774024-0CFBE496-33A7-4DD4-80CD-F1AEDF6A959A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26774024-0CFBE496-33A7-4DD4-80CD-F1AEDF6A959A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78b0faceae32efd8ddeeed18bec9609d06c419b5
P2860
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.